Kamada (KMDA) Cash & Equivalents (2012 - 2026)
Kamada's (KMDA) quarterly Cash & Equivalents came in at $32.9 million in Q1 2026, down 56.82% YoY from $76.2 million in Q1 2025, and down 56.38% on a QoQ basis from $75.5 million in Q4 2025.
Kamada (KMDA) Cash & Equivalents (2012 - 2026) Analysis & Trends
Kamada (KMDA) has 15 years of Cash & Equivalents data on file, last reported at $32.9 million in Q1 2026.
- Quarterly Cash & Equivalents fell 56.82% year-over-year to $32.9 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $32.9 million (down 56.82% YoY) and the FY2025 annual result came in at $75.5 million, down 3.78% from the prior year.
- Cash & Equivalents eased to $32.9 million in Q1 2026, from $75.5 million in the prior quarter.
- In the past five years, Cash & Equivalents ranged from a high of $31.3 billion in Q3 2022 to a low of $29933.0 in Q2 2022.
- A 5-year average of $1.9 billion and a median of $55.6 million in 2023 frame the typical range for Cash & Equivalents.
- Annual changes were most pronounced in 2022 — Cash & Equivalents sank 99.96% — and 2023, when it soared 72689.23%.
- Tracing KMDA's Cash & Equivalents over 5 years: stood at $34.3 million in 2022, then jumped by 62.42% to $55.6 million in 2023, then jumped by 40.97% to $78.4 million in 2024, then slipped by 3.78% to $75.5 million in 2025, then plunged by 56.38% to $32.9 million in 2026.
- The last three Cash & Equivalents figures came in at $32.9 million (Q1 2026), $75.5 million (Q4 2025), and $72.0 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.98 Bn | 43.02 Bn | - | 1.11 Bn |
| 2 | Teva Pharmaceutical Industries | 43.28 Bn | 39.62 Bn | 2.15 Bn | 3.66 Bn |
| 3 | Zoetis | 31.78 Bn | 30.11 Bn | 1.05 Bn | 1.48 Bn |
| 4 | Takeda Pharmaceutical | 28.71 Bn | 22.91 Bn | 5.10 Bn | 2.89 Bn |
| 5 | United Therapeutics | 22.25 Bn | 19.59 Bn | 683.80 Mn | 1.80 Bn |
| 6 | Viatris | 18.72 Bn | 17.83 Bn | 1.46 Bn | 886.50 Mn |
| 7 | Neurocrine Biosciences | 15.57 Bn | 15.18 Bn | 935.80 Mn | 332.40 Mn |
| 8 | Elanco Animal Health | 11.87 Bn | 11.34 Bn | 798.00 Mn | 530.00 Mn |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.97 Bn | - | 164.00 Mn |
| 10 | Kamada | 464.05 Mn | 434.58 Mn | 22.47 Mn | 29.47 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 29.47 Mn |
| Mar 31, 2026 | 32.92 Mn |
| Dec 31, 2025 | 75.47 Mn |
| Sep 30, 2025 | 72.00 Mn |
| Jun 30, 2025 | 65.99 Mn |
| Mar 31, 2025 | 76.25 Mn |
| Dec 31, 2024 | 78.44 Mn |
| Sep 30, 2024 | 72.00 Mn |
| Jun 30, 2024 | 56.55 Mn |
| Mar 31, 2024 | 48.19 Mn |
| Dec 31, 2023 | 55.64 Mn |
| Sep 30, 2023 | 52.60 Mn |
| Jun 30, 2023 | 21.79 Mn |
| Mar 31, 2023 | 27.12 Mn |
| Dec 31, 2022 | 34.26 Mn |
| Sep 30, 2022 | 31.25 Bn |
| Jun 30, 2022 | 29,933.00 |
| Mar 31, 2022 | 21.97 Mn |
| Dec 31, 2021 | 18.59 Mn |
| Sep 30, 2021 | 99.84 Mn |